期刊文献+

老年人骨髓增生异常综合征的治疗 被引量:1

原文传递
导出
摘要 骨髓增生异常综合征(MDS)是一组起源于造血干细胞的异质性髓系克隆性疾病,临床表现以难治性血细胞减少,骨髓细胞发育异常伴或不伴有幼稚细胞,高风险向急性髓系白血病(AML)转化。
作者 林艳娟
出处 《实用老年医学》 CAS 2014年第6期456-459,共4页 Practical Geriatrics
基金 国家和福建省临床重点专科建设项目
  • 相关文献

参考文献18

  • 1Adds L, Itzykson R, Fenaux P. My- elodysplastic syndromes [ J ].Lancet, 2014. [ Epub ahead of print].
  • 2Bammer C, Sperr WR, Kemmler G, et al. Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes [ J ]. J Geriatr Oucol. 2014. [ Epub ahead of print].
  • 3Lyons RM, Marek B J, Paley C, et al.Comparison of 24-month outcomes in chelated and non-chelated lower- risk patients with myelodysplastic syndromes in a prospective registry [J]. Leuk Re, 2014, 38 (2): 149-154.
  • 4铁过载诊断与治疗的中国专家共识[J].中华血液学杂志,2011,32(8):572-574. 被引量:109
  • 5无,吴德沛,阮长耿.骨髓增生异常综合征诊断与治疗专家共识[J].中华血液学杂志,2012,33(4):347-352. 被引量:75
  • 6Tatarelli C, Piccioni AL, Maurillo L, et al. Recombinant human eryth- ropoietin in very elderly patients with myelodysplastic syndromes : results from a retrospective study [ J ]. Ann Hematol, 2014. [ Epub ahead of printl.
  • 7Kadia TM, Borthakur G, Garcia- Manero G, et al. Final results of the phase lI study of rabbit anti- thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodys- plastic syndrome[ J ]. Br J Haematol, 2012, 157(3) :312-320.
  • 8Zeidan AM, Gore SD, McNally DL, et al. Lenalidomide performance in the real world: patterns of use and effectiveness in a Medicare population with myelodysplastic syn- dromes [ J ]. Cancer, 2013, 119 (21) :3870-3878.
  • 9Mallo M, Del Rey M, Ibifie M, et al. Response to lenalidomide in my- elodysplastic syndromes with del (5q) : influence of cytogenetics and mutations [ J ]. Br J Haematol, 2013, 162( 1 ) :74-86.
  • 10Leitch HA, Buckstein R, Shamy A, et al. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syn- dromes: a clinical practice guideline [ J]. Crit Rev Oncol Hematol, 2013, 85(2) :162-192.

二级参考文献5

  • 1Angelucci E, Barosi G, Camaschella C, et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica, 2008, 93:741-752.
  • 2Bennett JM, MDS Foundation' s Working Group on Transfusional Iron Overload. Consensus statement on iron overload in myelodys- plastic syndromes. Am J Hematol, 2008, 83:858-861.
  • 3Wells RA, Leber B, Buckstein R, et al. Iron overload in myelo- dysplastic syndromes:a Canadian consensus guideline. Leuk IRes, 2008, 32 : 1338-1353.
  • 4Cappellini MD, Pattoneri P. Oral iron chelators. Annu Rev Med, 2009, 60:25-38.
  • 5Marsh JCW, Ball SE, Cavenagh J, et al. Guidelines for the diag- nosis and management of aplastic anaemia. Br J Haematol, 2009, 147 :43-70.

共引文献181

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部